Because glutamine is thought to be a major fuel for developing gut, we tested the hypothesis that extensive small-bowel resection alters whole-body glutamine metabolism in vivo. Eleven infants and children who had undergone extensive small intestinal resection (residual bowel length: 35 * 13 cm; mean ? SD) and four control infants received 4-h primed, continuous i.v. infusions of L-[I-'"]leucine and L-[2-"N]glutamine in the postabsorptive state. The appearance rates of glutamine and leucine into plasma were determined from stable isotope enrichments in plasma at steady state. We observed the following: 1 ) Regardless of intestinal status, leucine and glutamine fluxes were higher in infants than values previously reported for adults. 2) Small-bowel resection was associated with a
The prominent role of the small intestine in glutamine utilization has been established in a variety of animal species (1-3). In the rat, glutamine uptake by the small intestine accounts for 20% of overall glutamine utilization; glutamine oxidation supplies a third of the total energy requirement of this tissue (3). In humans, glutamine concentration was found to be 13-17% higher in arterial blood than in portal blood in adults undergoing elective cholecystectomy (4) or in multitrauma patients submitted to exploratory laparotomy (5). Recently, we have developed stable isotope methods to quantitate rates of glutamine production and utilization in vivo (6, 7), and we observed that the rate of whole-body glutamine utilization was decreased about 20% in adult patients after extensive resection of the small intestine. This was observed despite the fact that patients were studied several months after surgery and were in a near normal nutritional status long after they had been weaned from PN (8). These findings suggested that intestinal resection per se caused a reduction in overall glutamine utilization. Studies performed in animals have shown that glutamine reduction in glutamine appearance rate (568 * 124 pmol . kg lean body m a s s ' h ' in short-bowel syndrome infants versus 816 2 149 pmol -kg lean body mass-' . h-' in control infants;~ < 0.05). 3 ) In contrast, leucine appearance rate was unaltered in short-bowel syndrome patients. The findings suggest that the small intestine plays a prominent role in glutamine metabolism in human infants. Ra, appearance rate Ra,,,, glutamine flux PN, parenteral nutrition is used by the developing (9) as well as the adult small intestine (3). T o our knowledge, however, neither glutamine kinetics nor the contribution of the small intestine to glutamine metabolism has been assessed in human infants. If glutamine is indeed a major fuel for the human infant small intestine, extensive bowel resection may alter whole-body glutamine kinetics in that population. We therefore used tracer techniques to quantitate glutamine kinetics in a group of children with short-bowel syndrome.
METHODS
Patients. Informed consent was obtained from the parents of all the infants studied according to protocols approved by the Ethics Committee of Necker EnfantsMalades Hospital. A total of 15 children were studied: four controls and 11 children who had undergone extensive small intestinal resection. Inclusion criteria were 1 ) a fair and stable nutritional status; 2) the absence of surgical procedure in the 6 mo before study; 3) the absence of sepsis or neoplasia; 4) a residual small-bowel length of less than 50 cm; and 5) a normal growth velocity for age over the few months before study. Extensive enterectomy had been performed during the neonatal period because of intestinal atresia (n = 5), volvulus (n = 2), extensive intestinal angioma (n = 2), necrotizing enterocolitis (n = I), and teratoma (n = 1). Small-bowel length was measured at the time of surgery along the antimesenteric side. Control patients had an intact small bowel. They were hospitalized for evaluation of failure to thrive (n = 2), rectal Hirschsprung's disease (n = I), or Alagille's syndrome (a syndrome associating cholestasis, cardiac anomalies, butterfly vertebrae, embryotoxon, and abnormal facial features; n = 1). None of the controls had any evidence of sepsis, neoplasia, or any disease of the gastrointestinal tract, and none had undergone surgery in the recent past. Patients and controls had the same energy intake, with 10% of total energy (parenteral, oral, or both) provided as protein. Skinfold thickness was measured at four sites by the same observer, using a Holtain-Harpenden skinfold caliper (Holtain Ltd., Grymmych, Wales, UK). Body density was calculated based on skinfold measurements (lo), and the percentage of body weight accounted for by fat mass was derived from body density (11). Lean body mass was calculated as the difference between body weight and fat mass.
Protocol design. All infants were studied in the postabsorptive state. The night before the study, patients were admitted to the nutrition unit and received their regular oral or PN intake until 0600 h the next morning. Studies were begun at 1000 h, i.e. 4 h after discontinuation of oral or parenteral feeding. Patients who already had a central catheter received the isotopes through the central line. When children had no central catheter, an indwelling "butterfly" needle was inserted into a superficial vein of the arm to infuse the isotopes. Another indwelling needle was placed on the opposite limb for blood sampling. At 1000 h, a baseline 1-mL blood sample was drawn to determine background isotopic enrichment in plasma amino acids, and a primed, continuous infusion of sterile, pyrogen-free solutions providing 3 pmol kg-' -h-' L-[I-'3~]leucine and 10 pmol . kg-' . h-' ~-[ 2 -'~~]~l u t a m i n e (90% 1 3 c and 97% "N, respectively; both from CEA, Gif-sur-Yvette, France) was administered i.v. for 4 h using a calibrated syringe pump (Vial Medical, VClizyVillacoublay, France) (6, 8). During the last 2 h of infusion, the forearm was heated (~6 0°C ) with a heating pad to obtain four 1-mL arterialized venous blood samples (12) at 30-min intervals.
Analyficalprocedures. Isotopic enrichments were determined in plasma amino acids by gas chromatographymass spectrometry using a Nermag R 1010 T instrument (Nermag, Argenteuil, France) with a precision of approximately 1%. Glutamine was isolated for derivatization by passing the deproteinized, neutralized plasma over disposable anion-exchange columns as previously described (7). Plasma glutamine was analyzed as its N-acetyl, n-propyl ester derivative (7) and leucine as its N-trifluoroacetyl, n-butyl derivative (8, 13). Plasma glutamine concentrations (pM) were determined by reverse isotope dilution of a *~, -~l u t a m i n e (Tracer Technologies, Somerville, MA) internal standard that was added to the samples at the time of sampling (7). Calculations. Amino acid Ra were calculated using standard equations for steady state:
where i is the tracer infusion rate (pmol . kg-' . h-'), and
Ei and Ep (mole % excess) are the tracer enrichments in the infusate and plasma, respectively, at steady state. Isotopic steady state was defined by a coefficient of variation < 10% over the last 2 h of infusion. Under conditions of steady state, the Ra of an amino acid is equal to its rate of disappearance, and Ra therefore measures both the production and utilization of the amino acid.
Because leucine is an essential amino acid, its Ra (Ra,,,)
is entirely derived from protein breakdown in the postabsorptive state. In contrast, glutamine, a dietary nonessential amino acid, has two inflow components to its flux, release from protein breakdown (BGLN) and de Comparisons between groups were performed using nonparametric Mann-Whitney test.
RESULTS
Relevant clinical and nutritional characteristics of the infants are summarized in Table 1 . Six of the infants who had undergone small-bowel resection received supplementation with PN (patients 1-6) in addition to oral feeding. In this group, oral feeding represented 30 to 70% of total energy intake. Five infants with small-bowel resection (patients 7-11) had been weaned from PN 21 -c 12 mo before the study.
Isotopic enrichment reached steady state in plasma glutamine and leucine over the last 2 h of tracer infusion (Table 2) . Whether expressed per kg of body weight or per kg of lean body mass, RaGLN was significantly decreased in short-bowel syndrome patients. The reduction in glutamine flux seems to be caused by a lower rate of de novo synthesis, yet the difference failed to reach statistical significance. There was no difference between the two groups with regard to plasma glutamine concentrations or rates of protein turnover (whether expressed as glutamine release from protein breakdown or leucine flux). Within the small population studied, there was no correlation between RaGLN and age or between Ra,,, and residual small-bowel length. 
DISCUSSION
enterectomy; therefore, alterations in overall protein hoBased on i.v. infusion of stable isotope-labeled amino meostasis could not explain our finding on glutamine.
acids, the current study provides evidence for a lower The reduction of Ra,,, in short-gut infants is unlikely rate of whole-body glutamine production and utilization to result from differences in nutritional status, dietary in infants who have undergone extensive resection of the intake, Or because I ) the patients' u small intestine. ~l~h~~~h glutamine metabolism was as-nutritional status was fair; 2) their energy intake was sessed at the level of the whole body rather than directly similar to that of controls ( Table 1) ; and 3 ) their glutamine measured in the intestinal bed, the present findings sug-Ra Was still decreased when expressed Per kg of lean gest that the lower glutamine flux may be attributed to body mass-an estimate of the body's metabolically acenterectomy per se. Indeed, whole-body protein turn-tive mass (14) . The route of nutrient delivery did not over (as reflected by leucine flux) was not altered by seem to have any major impact on glutamine Ra, inas- Mean + S D 1 9 4 + 5 7 4 8 4 + 1 2 3 t 2 2 8 2 6 0 5 6 8 + 1 2 4 t 3 9 6 + 1 0 4 1 7 5~1 ( M ) 5 0 9 + 1 3 5 I . l 6 + 0 . much as there was no detectable difference between those who had been weaned from PN and those who were still receiving supplements. Furthermore, all the infants were free of other disease processes that may affect glutamine metabolism such as cancer, sepsis, recent surgery, or disease of the immune system. Finally, we did not observe any correlation between age and Ra,,, in the infants studied; it is therefore unlikely that slight differences in patients' ages between groups could account for the findings.
Because our patients were studied more than 6 mo after surgery, some compensatory small-bowel growth or adaptation (15, 16) had most likely already taken place at the time of study; we do not have any estimate of the extent of this compensatory growth. However, if we assume the small-bowel length to be =270 cm in a normal neonate (17), our patients only retained =6-22% of their small bowel after surgery. After such an extensive resection, it is unlikely that small-bowel length had returned to 100% by the time of study; it is therefore safe to assume that our patients still had a decreased small intestinal mass compared with controls. Indeed, although the patients who had been completely weaned off PN at the time of study (patients 7-11; Table 2) presumably had experienced the greater compensatory intestinal growth, their glutamine Ra did not differ from that of patients who were still dependent on PN (patients 1-6).
Windmueller and Spaeth were first to quantitate the uptake of glutamine by the rat small intestine (3). In the human, Felig et al. (4) were first to document a positive arterioportal glutamine concentration gradient in vivo in adults undergoing elective cholecystectomy. Our present results are consistent with a previous study from our laboratory that used the same model and methodology to assess glutamine metabolism in the adult (8). The use of the short-bowel syndrome as an investigative model thus suggests that the small intestine is a target organ for glutamine utilization in both adults and infants in the human species.
Because glutamine turnover was measured at steady state, its reduction reflects a decline in both glutamine utilization and glutamine production. From our data, it cannot be ascertained which of these two processes occurred first. The reduction in glutamine Ra associated with enterectomy seems to be accounted for by a lower rate of de novo glutamine synthesis ( Table 2 ). The difference in de novo synthetic rates failed to reach statistical significance in the current study; it did, however, reach significance in adult short-bowel syndrome patients (8). Nevertheless, it has to be kept in mind that, although Ra,,, is directly measured, glutamine de novo synthesis is a calculated value rather than a direct measurement and is therefore prone to large errors. Using arteriovenous gradient determination. other workers (18) have bowel. In the postabsorptive state, the release of glutamine by "peripheral" skeletal muscle exceeds that of any other amino acid but alanine (19). A recent study confirms that skeletal muscle is the main source of glutarnine; it accounts for =67% of glutamine Ra in healthy postabsorptive humans (20). Taken together, these studies suggest that although glutamine production takes place predominantly in peripheral (extrasplanchnic) tissues it may be controlled by the glutamine-requiring, i.e. splanchnic, tissues, among which the small bowel may play a prominent role.
Such an interorgan adaptive process should be triggered by a signal. The nature of this signal cannot be ascertained from the present data. Theoretically, the plasma glutamine concentration itself could be such a signal, inasmuch as glutamine is known to exert feedback inhibition on glutamine synthetase in cultured cells in vitro (21). Plasma glutamine concentrations did not differ between groups in the present study. However, the infants were studied long after enterectomy, and we could have missed transient alterations in glutamine concentration.
It is of interest to compare the amino acid kinetics obtained in the present study with those in adults (6, 8). Glutamine Ra was higher in control infants than in healthy adults (715 versus 344 pmol kg-' . h-I); the same holds true for short-bowel syndrome infants compared with short-bowel syndrome adults (484 versus 273 pmol kgp' hp'; Figs. 1 and 2) . Similarly, leucine Ra was higher in infants than in adults (194 versus 88 ~m o l -kgp' . h p ' in short-bowel syndrome patients; 214 versus 89 pmol -kg-' . h-' in controls). These higher amino acid fluxes are consistent with previous data reported for whole-body leucine fluxes in human newborns (22, 23). The higher leucine fluxes may be attributed to the higher protein turnover associated with the growth process (23). As for glutamine, several factors could previously reported a marked decrease in the extremity 
